Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription

Articles published in Invest Radiol

Retrieve available abstracts of 5 articles:
HTML format
Text format

Single Articles

    August 2018
  1. BARRETT T, Riemer F, McLean MA, Kaggie J, et al
    Quantification of Total and Intracellular Sodium Concentration in Primary Prostate Cancer and Adjacent Normal Prostate Tissue With Magnetic Resonance Imaging.
    Invest Radiol. 2018;53:450-456.
    PubMed     Text format     Abstract available

    April 2018
  2. HE D, Chatterjee A, Fan X, Wang S, et al
    Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis.
    Invest Radiol. 2018 Apr 27. doi: 10.1097/RLI.0000000000000466.
    PubMed     Text format     Abstract available

    October 2017
  3. WEISS J, Martirosian P, Notohamiprodjo M, Kaufmann S, et al
    Implementation of a 5-Minute Magnetic Resonance Imaging Screening Protocol for Prostate Cancer in Men With Elevated Prostate-Specific Antigen Before Biopsy.
    Invest Radiol. 2017 Oct 26. doi: 10.1097/RLI.0000000000000427.
    PubMed     Text format     Abstract available

    September 2017
  4. PEREZ-LOPEZ R, Nava Rodrigues D, Figueiredo I, Mateo J, et al
    Multiparametric Magnetic Resonance Imaging of Prostate Cancer Bone Disease: Correlation With Bone Biopsy Histological and Molecular Features.
    Invest Radiol. 2017 Sep 12. doi: 10.1097/RLI.0000000000000415.
    PubMed     Text format     Abstract available

    May 2017
  5. LAGEMAAT MW, Philips BW, Vos EK, van Uden MJ, et al
    Feasibility of Multiparametric Magnetic Resonance Imaging of the Prostate at 7 T.
    Invest Radiol. 2017;52:295-301.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.